TotalMarketCap

Immutep

IMMPNasdaq AustraliaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$20.638 M

$2.80 -5.08%

Close of 6 Nov 2026

As of 6 Nov 2026, Immutep (IMMP) has a market capitalization of $20.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

1,473,721,306

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #380IGC PharmaIGC$21.6M
  2. #381Seres TherapeuticsMCRB$21.3M
  3. #382ImmutepIMMP$20.6M
  4. #383Atossa TherapeuticsATOS$20.1M
  5. #384TherapeuticsMDTXMD$20.0M

What if Immutep were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,831,040

Per share 1,368,228× higher

Bitcoin $1.53T

$207,290.89

Per share 74,032× higher

Apple $5.02T

$680,516.64

Per share 243,042× higher

Or at a round number

$50.0M$100.0M$200.0M$500.0M

Where these numbers come from

Share counts and financials for Immutep are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.